Skip to main content
Recent Quotes
My Watchlist
Indicators
Markets
Stocks
ETFs
Tools
Markets:
Overview
News
Currencies
International
Treasuries

IGC Pharma, Inc. Common Stock (NY:IGC)

0.4150 UNCHANGED
Streaming Delayed Price Updated: 8:00 PM EDT, Jul 10, 2025 Add to My Watchlist
Quote
Overview Detailed Quote Charting Historical Prices
News
All News News Headlines Press Releases
Research
Quarterly Reports Insider Filings Other Filings

Price and Volume

Detailed Quote
Volume 362,957
Open 0.4150
Bid (Size) 0.3572 (26)
Ask (Size) 0.3737 (1)
Prev. Close 0.4150
Today's Range 0.4150 - 0.4150
52wk Range 0.2525 - 0.4980
Shares Outstanding 49,784,017
Dividend Yield N/A
Chart for (: )
Intraday 1 Week 1 Month 3 Month 1 Year 3 Year 5 Year

Top News

More News
IGC Pharma Introduces MINT-AD: Proprietary AI Platform to Predict Alzheimer's Risk and Accelerate Early Detection
Via ACCESS Newswire
In today's session, these stocks are experiencing unusual volume.
Let's have a look at what is happening on the US markets on Thursday. Below you can find the stocks with an unusual volume in today's session. 
Via Chartmill

Performance

YTD
+16.2%
+16.2%
1 Month
+34.2%
+34.2%
3 Month
+54.3%
+54.3%
6 Month
+20.3%
+20.3%
1 Year
-1.4%
-1.4%

More News

Read More
Get insights into the top gainers and losers of Thursday's pre-market session.
Via Chartmill
12 Health Care Stocks Moving In Thursday's Pre-Market Session
Via Benzinga
Insights Ahead: IGC Pharma's Quarterly Earnings
Via Benzinga
Why WK Kellogg Shares Are Trading Higher By Over 50%; Here Are 20 Stocks Moving Premarket
Via Benzinga
Massive 69.4% Surge for IGC Pharma in After-Hours Trading: Here's Why
Via Benzinga
12 Health Care Stocks Moving In Wednesday's After-Market Session
Via Benzinga
What's going on in today's after hours session
Via Chartmill
IGC Pharma: Fiscal Year 2025 Financial and Operational Highlights - A Year of Transformative Progress in Alzheimer's Innovation
Via ACCESS Newswire
US Stocks Likely To Open Higher, Continuing Record-Setting Advances: June Has Never Seen An All-Time High Since 1950, Highlights Expert
Via Benzinga
Progress Software, Exicure And 3 Stocks To Watch Heading Into Monday
Via Benzinga
IGC Pharma to Host Fiscal Year-End 2025 Shareholder Update Call on Monday June 30, 2025
Via ACCESS Newswire
IGC Pharma Expands CALMA Trial to Oklahoma, Partnering with Dr. David McCoy at Tekton Research in Yukon
Via ACCESS Newswire
IGC Pharma's Puerto Rico CALMA Trial Site Offers Strategic Opportunity in High-Prevalence Alzheimer's Market
Via ACCESS Newswire
IGC Pharma Presents Genetic Toxicology Safety Data on API in IGC-AD1, at the 2025 Genetic Toxicology Association Meeting
Via ACCESS Newswire
12 Health Care Stocks Moving In Thursday's After-Market Session
Via Benzinga
IGC Pharma Welcomes Strategic Investment from Advisors
Via ACCESS Newswire
IGC Pharma Welcomes Industry Leaders to Advisory Board, Supporting Alzheimer's Innovation and AI-Driven Programs
Via ACCESS Newswire
IGC Pharma Expands CALMA Alzheimer's Phase 2 Trial with Prestigious Research Site at Butler Hospital's Memory and Aging Program
Via ACCESS Newswire
IGC Pharma Announces CALMA Phase 2 Trial Expansion with the Addition of Miami Jewish Health
Via ACCESS Newswire
IGC Pharma's Phase 2 Clinical Trial Interim Data Demonstrates Significant Reduction in Sleep Disturbances
Via ACCESS Newswire
IGC Pharma Announces CALMA Phase 2 Trial Expansion with the Addition of Canadian Hamilton Health Sciences
Via ACCESS Newswire
IGC Pharma Expands CALMA Trial with Addition of BayCare Health System in Florida
Via ACCESS Newswire
IGC Pharma Announces Coverage Report by Ascendiant Capital Markets about the "Reports Q3 results. We believe more positive clinical data in 2025 to be strong catalysts for stock. Raising P/T to $4.25"
Via ACCESS Newswire

Frequently Asked Questions

Is IGC Pharma, Inc. Common Stock publicly traded?
Yes, IGC Pharma, Inc. Common Stock is publicly traded.
What exchange does IGC Pharma, Inc. Common Stock trade on?
IGC Pharma, Inc. Common Stock trades on the New York Stock Exchange
What is the ticker symbol for IGC Pharma, Inc. Common Stock?
The ticker symbol for IGC Pharma, Inc. Common Stock is IGC on the New York Stock Exchange
What is the current price of IGC Pharma, Inc. Common Stock?
The current price of IGC Pharma, Inc. Common Stock is 0.4150
When was IGC Pharma, Inc. Common Stock last traded?
The last trade of IGC Pharma, Inc. Common Stock was at 07/10/25 08:00 PM ET
What is the market capitalization of IGC Pharma, Inc. Common Stock?
The market capitalization of IGC Pharma, Inc. Common Stock is 20.66M
How many shares of IGC Pharma, Inc. Common Stock are outstanding?
IGC Pharma, Inc. Common Stock has 21M shares outstanding.
Stock Quote API & Stock News API supplied by www.cloudquote.io
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms Of Service.